| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |